Cherniack R M
Division of Pulmonary Science and Critical Care Medicine, University of Colorado School of Medicine, Denver, USA.
Clin Chest Med. 1995 Dec;16(4):567-81.
Asthma is a condition in which there is airway hyperresponsiveness, with the propensity for widespread, reversible airways narrowing on exposure to diverse inciting factors (triggers). Inhalation of nonspecific agents such as methacholine or histamine leads to bronchoconstriction in most cases, and in some, the bronchoconstriction follows exposure to specific agents such as antigen or occupational irritants. Chest tightness and cough, which are the most common symptoms of asthma, are probably the result of inflammation mucus plugs, edema, or smooth muscle constriction in the small peripheral airways. Because major obstruction of the peripheral airways can occur without recognizable increases of airway resistance or FEV1, the physiologic alterations in acute exacerbations are generally subtle in the early stages. Poorly ventilated alveoli subtending obstructed bronchioles continue to be perfused, and as a consequence, the P(A-a)O2 increases and the PaO2 decreases. At this stage, ventilation is generally increased, with excessive elimination of carbon dioxide and respiratory alkalemia. In the more severe exacerbation, lung volume is increased and the static volume-pressure curve is shifted up (lung volume is greater) and to the left (pressure is lower) while the shape of the curve is unaltered. The airway obstruction is reversible and there is generally improvement in air flow rates following administration of beta-agonists and anti-inflammatory agents. The changes in mechanical properties are also reversible, and therapeutic intervention usually results in a shift of the PV curve downward toward the normal position, for example, a decrease in TLC and an increase in the elastic recoil pressure at any particular lung volume. Failure to take these changes into account may underestimate the impact of therapy. The PaO2 decreases (and the P(A-a)O2 increases) as the work of breathing increases, and when it becomes excessive (and/or the FEV1 falls below 20% to 25%), the PaCO2 begins to increase. Therefore, in any patient with asthma, a decreasing PaO2 and an increasing PaCO2, even into the normal range, indicates severe airway obstruction that is leading to respiratory muscle fatigue and patient exhaustion.
哮喘是一种气道高反应性疾病,接触多种诱发因素(触发因素)时易于出现广泛、可逆的气道狭窄。吸入非特异性药物如乙酰甲胆碱或组胺在大多数情况下会导致支气管收缩,在某些情况下,支气管收缩是在接触特异性药物如抗原或职业性刺激物之后发生。胸部发紧和咳嗽是哮喘最常见的症状,可能是外周小气道炎症、黏液栓、水肿或平滑肌收缩的结果。由于外周气道的严重阻塞可能在气道阻力或第一秒用力呼气量(FEV1)无明显增加的情况下发生,急性加重期的生理改变在早期通常很细微。通气不良的肺泡所对应的阻塞性细支气管仍有血流灌注,因此,肺泡-动脉血氧分压差[P(A-a)O2]增大,动脉血氧分压(PaO2)降低。在这个阶段,通气通常会增加,二氧化碳过度排出,出现呼吸性碱血症。在更严重的加重期,肺容积增加,静态容积-压力曲线向上(肺容积更大)和向左(压力更低)移位,而曲线形状不变。气道阻塞是可逆的,吸入β受体激动剂和抗炎药物后气流速度通常会改善。力学特性的改变也是可逆的,治疗干预通常会使压力-容积(PV)曲线向下移至正常位置,例如,肺总量(TLC)降低,在任何特定肺容积下弹性回缩压增加。未考虑这些变化可能会低估治疗效果。随着呼吸功增加,PaO2降低(且P(A-a)O2增大),当呼吸功过大(和/或FEV1降至20%至25%以下)时,PaCO2开始升高。因此,在任何哮喘患者中,即使PaO2降低和PaCO2升高至正常范围,也表明存在严重的气道阻塞,导致呼吸肌疲劳和患者衰竭。